General Motors
GM
$80.43
+1.44%
General Motors Company is a global automotive manufacturer operating in the Consumer Cyclical sector, designing, building, and selling cars, trucks, and SUVs under brands like Chevrolet, GMC, Cadillac, and Buick. The company is a dominant market leader in the US, having regained its market share leadership in 2022 and holding a 17.4% share in 2025, and operates through three core segments: GM North America, GM International, and its captive finance arm, GM Financial. The current investor narrative is dominated by a debate over its ability to capitalize on competitor supply chain issues to gain market share, particularly in high-margin trucks, while navigating a volatile earnings trajectory marked by a significant Q4 2025 loss, and managing the strategic pivot of its Cruise autonomous vehicle unit towards personal AVs after a high-profile setback.…
GM
General Motors
$80.43
Related headlines
Investment Opinion: Should I buy GM Today?
Rating & Thesis: GM is rated a Hold. The core thesis is that the stock presents a compelling but high-risk value proposition, where the deep discount in its forward valuation (P/E of 5.63x) is justified by severe earnings volatility and operational uncertainty, requiring investors to wait for concrete evidence of a sustained profit recovery before committing capital.
Supporting Evidence: The Hold rating is supported by four key data points: 1) The massive gap between the trailing P/E (27.72x) and forward P/E (5.63x) reflects sky-high expectations for an earnings rebound to an estimated $14.71 EPS. 2) Quarterly profitability is wildly inconsistent, with gross margins swinging from 6.41% in Q3 to -2.48% in Q4. 3) Despite this, the company's financial foundation is solid, with strong TTM free cash flow of $11.07 billion and a current ratio of 1.17. 4) Technicals show the stock is in a corrective phase, down -3.72% over six months and underperforming the market YTD, suggesting near-term momentum is weak.
Risks & Conditions: The two biggest risks are a prolonged failure to return to stable profitability and a compression of its forward multiple if confidence erodes. This Hold would upgrade to a Buy if the company delivers two consecutive quarters of positive, expanding gross margins (e.g., above 6%) and the stock holds above key technical support around $72. It would downgrade to a Sell if Q4-style losses recur, revenue growth remains negative, or the stock breaks below $72 support. Relative to its own history and the auto sector, GM is fairly valued on a forward basis but richly valued on a trailing basis, indicating the market is paying for promised future profits that are not yet assured.
Sign up to view all
GM 12-Month Price Forecast
GM is a classic 'show me' story trading on the promise of a dramatic earnings turnaround. The valuation is compelling if the recovery occurs, but the operational evidence remains contradictory and volatile. The neutral stance reflects this high-risk/high-reward dichotomy, where the probability-weighted base case suggests limited near-term upside. Confidence is medium due to the limited analyst coverage (5 firms) and the stock's high sensitivity to quarterly results. The stance would upgrade to bullish on confirmation of two consecutive quarters of stable, positive margins. It would turn bearish if the next earnings report shows a recurrence of Q4's deeply negative profitability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on General Motors's 12-month outlook, with a consensus price target around $104.56 and implied upside of +30.0% versus the current price.
Average Target
$104.56
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$64 - $105
Analyst target range
Analyst coverage for GM is limited, with only 5 analysts providing estimates, which suggests it may be under-followed relative to its market cap and can lead to higher volatility and less efficient price discovery. The available data shows a consensus revenue estimate of $203.60 billion and an EPS estimate of $14.71 for the period, but a consensus price target and explicit Buy/Hold/Sell distribution are not available in the provided data, preventing a calculation of implied upside or a clear sentiment read. Without a consensus price target or rating distribution, it is difficult to gauge analyst conviction; however, the provided institutional ratings show recent actions including an upgrade to Outperform by Wolfe Research and maintained Buy or Outperform ratings from firms like Barclays, UBS, and RBC Capital, alongside a lone Underweight from Wells Fargo, indicating a generally bullish tilt among the firms that do cover the stock, albeit with limited breadth of coverage.
Bulls vs Bears: GM Investment Factors
The investment debate for GM hinges on the tension between its deeply discounted forward valuation and its highly volatile, recently negative earnings trajectory. The bull case is anchored on the expectation of a sharp earnings normalization, supported by strong cash flow and a strategic market share opportunity. The bear case emphasizes the stock's vulnerability given its elevated trailing multiple and the real risk that the expected profit recovery fails to materialize. Currently, the bear side presents stronger near-term evidence due to the concrete Q4 loss, revenue decline, and ongoing technical correction. However, the extreme divergence between the trailing P/E (27.72x) and forward P/E (5.63x) is the single most important factor; its resolution—either through earnings delivery or multiple compression—will decisively determine the stock's direction.
Bullish
- Deep Forward Valuation: GM's forward P/E of 5.63x is exceptionally low, pricing in a massive earnings recovery from the Q4 2025 loss. This represents a deep value proposition if the company meets the analyst EPS estimate of $14.71, implying a significant earnings multiple expansion potential.
- Despite earnings volatility, GM generated $11.07 billion in trailing twelve-month free cash flow. This strong cash generation provides a financial cushion to manage its high debt-to-equity ratio of 2.13, fund operations, and return capital to shareholders.
- Market Share Gains & Strategic Opportunity: GM holds a leading 17.4% US market share in 2025, up 60 basis points from 2024. Recent news indicates the company is strategically ramping up truck production to capitalize on competitor supply chain issues, presenting a near-term opportunity to capture high-margin profits.
- Strong Long-Term Momentum: The stock has delivered a powerful 1-year return of +64.88%, significantly outperforming the SPY's +24.99%. This long-term uptrend, despite recent correction, suggests underlying investor confidence in the company's strategic direction and recovery narrative.
Bearish
- Extreme Earnings Volatility: Profitability is highly inconsistent, with Q4 2025 showing a net loss of -$2.70 billion and a gross margin of -2.48%, a stark reversal from Q3's $1.33 billion profit and 6.41% margin. This quarterly swing from deep losses to profits creates significant uncertainty for investors.
- Elevated Trailing Valuation: The trailing P/E of 27.72x is elevated for an auto manufacturer and sits near the top of its own volatile historical range. This suggests the market has already priced in a full earnings recovery, leaving the stock vulnerable to any disappointment.
- Recent Technical Correction & Underperformance: The stock is in a corrective phase, down -3.72% over the past six months and underperforming the SPY by -11.60% year-to-date. Its beta of 1.3 amplifies downside moves, and the price is testing support after retreating from the 52-week high of $87.62.
- High Financial Leverage: A debt-to-equity ratio of 2.13 indicates significant financial leverage. While mitigated by strong cash flow, this high debt load increases financial risk, especially in a rising interest rate environment or during an industry downturn.
GM Technical Analysis
The stock is in a sustained long-term uptrend but has recently entered a corrective phase. The 1-year price change of +64.88% indicates powerful momentum over the past year, yet the current price of $79.29 sits at approximately 90% of its 52-week range ($47.63 to $87.62), suggesting it has retreated from recent highs and is now testing the upper bounds of a consolidation zone. This positioning near the top of the range, but off the peak, reflects a market balancing optimism from the long-term trend with near-term profit-taking and uncertainty. Recent momentum shows a sharp deceleration, with the stock up 9.17% over the past month but down -3.72% over the past six months, indicating the strong 1-year trend has stalled and reversed into a short-term downtrend. This divergence, where the 1-month gain is positive but the 6-month is negative, signals a potential relief rally within a broader corrective phase, as evidenced by the stock's -11.60% year-to-date underperformance relative to the SPY. Key technical support is anchored at the 52-week low of $47.63, while immediate resistance is at the 52-week high of $87.62. A decisive breakout above $87.62 would signal a resumption of the primary uptrend, whereas a breakdown below the recent lows around $72 could accelerate the correction. The stock's beta of 1.3 indicates it is 30% more volatile than the broader market, which amplifies both upside and downside moves and necessitates careful risk management for investors.
Beta
1.30
1.30x market volatility
Max Drawdown
-16.2%
Largest decline past year
52-Week Range
$48-$88
Price range past year
Annual Return
+66.9%
Cumulative gain past year
| Period | GM Return | S&P 500 |
|---|---|---|
| 1m | +2.1% | -0.2% |
| 3m | +5.0% | +14.0% |
| 6m | -3.0% | +7.8% |
| 1y | +66.9% | +25.3% |
| ytd | -0.7% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GM Fundamental Analysis
Revenue growth has been volatile and recently negative, with Q4 2025 revenue of $45.29 billion representing a -5.06% year-over-year decline, a stark reversal from the positive growth seen in prior quarters of 2025. This quarterly contraction, driven by a significant gross margin compression to -2.48% in Q4, indicates near-term operational headwinds, though segment data shows the core GM North America business generated $240.64 billion in annual revenue, underscoring its scale. Profitability is highly inconsistent, as evidenced by a Q4 2025 net income loss of -$2.70 billion and a gross margin of -2.48%, which contrasts sharply with the profitable Q3 2025 net income of $1.33 billion and a gross margin of 6.41%. This quarterly volatility, with margins swinging from deeply negative to positive, points to significant cost or pricing pressures, likely from one-time charges or market conditions, though the trailing twelve-month net margin remains positive at 1.46%. The balance sheet and cash flow reveal a company with a leveraged but cash-generative profile, with a debt-to-equity ratio of 2.13 indicating significant financial leverage, yet it maintains a strong current ratio of 1.17 for liquidity. Crucially, the company generated robust free cash flow of $11.07 billion over the trailing twelve months, providing ample internal funding for operations, capital expenditures, and shareholder returns, which mitigates the risks associated with its high debt load.
Quarterly Revenue
$45.3B
2025-12
Revenue YoY Growth
-0.05%
YoY Comparison
Gross Margin
-0.02%
Latest Quarter
Free Cash Flow
$11.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GM Overvalued?
Given the company's positive trailing net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 27.72x, while the forward PE is significantly lower at 5.63x; this massive gap implies the market expects a substantial recovery in earnings over the next twelve months, pricing in the anticipated rebound from the recent quarterly loss. Compared to typical auto manufacturer valuations, GM's trailing PE of 27.72x appears elevated, though its forward PE of 5.63x suggests a deep value proposition if earnings estimates are met, indicating the stock is currently priced for a sharp earnings normalization. Historically, the stock's own valuation has been highly volatile; the current trailing PE of 27.72x is near the top of its recent historical range, which has seen negative PE values during loss-making quarters and single-digit PEs during profitable periods. Trading near historical highs on a trailing basis suggests the market is pricing in a full earnings recovery, leaving little room for error, and making the stock sensitive to any disappointment in the anticipated profit rebound.
PE
24.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -7x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: GM's primary financial risk stems from extreme earnings volatility, as evidenced by the swing from a Q3 2025 net income of $1.33 billion to a Q4 loss of -$2.70 billion. This inconsistency, coupled with a high debt-to-equity ratio of 2.13, creates a leveraged balance sheet that is sensitive to operational missteps or economic downturns. While robust TTM free cash flow of $11.07 billion provides a buffer, the recent Q4 gross margin of -2.48% indicates acute pricing or cost pressures that could derail the projected earnings recovery and strain cash generation.
Market & Competitive Risks: The stock faces significant valuation compression risk, as its trailing P/E of 27.72x is elevated for the auto sector and leaves little room for error. Competitive risks are heightened as GM attempts to capitalize on Ford's temporary weakness; the recent news of Ford's key supplier restarting removes a headwind for its rival, potentially shortening GM's window of opportunity. Furthermore, the stock's beta of 1.3 means it is 30% more volatile than the market, amplifying downside moves during sector-wide sell-offs or if growth fears resurface.
Worst-Case Scenario: The worst-case scenario involves a failure of the earnings rebound, where Q4 2025's losses prove not to be an anomaly but a sign of deeper structural issues, perhaps from failed pricing power or unsustainable costs. This could trigger multiple compression from the current forward P/E of 5.63x back towards historical lows seen during loss-making periods, combined with analyst downgrades. A realistic downside could see the stock re-test its 52-week low of $47.63, representing a potential loss of approximately -40% from the current price near $79, exacerbated by its high beta during a broader market decline.
FAQ
The key risks, in order of severity, are: 1) Operational Risk: Extreme earnings and margin volatility, evidenced by the swing from a Q3 gross margin of 6.41% to a Q4 margin of -2.48%, threatens the investment thesis. 2) Valuation Risk: The elevated trailing P/E of 27.72x leaves no room for error; any earnings disappointment could trigger a sharp multiple compression. 3) Financial Risk: High debt-to-equity of 2.13 increases vulnerability to economic downturns or rising rates. 4) Competitive/Macro Risk: The window to capitalize on competitor weakness may close, and the stock's beta of 1.3 amplifies downside during market sell-offs.
The 12-month forecast is bifurcated, with a base case target range of $80-$90 (50% probability), a bull case of $95-$105 (30% probability), and a bear case of $55-$70 (20% probability). The base case, which is most likely, assumes a bumpy but materializing earnings recovery towards the analyst EPS estimate of $14.71, with the stock oscillating in a range. The forecast hinges almost entirely on the company's ability to stabilize profitability. The wide range of outcomes reflects the high uncertainty stemming from GM's recent quarterly loss and revenue decline.
GM's valuation presents a paradox: it appears overvalued on a trailing basis but deeply undervalued on a forward basis. The trailing P/E of 27.72x is elevated for an auto manufacturer and prices in a full recovery. Conversely, the forward P/E of 5.63x is exceptionally low and suggests significant undervaluation if earnings estimates are met. Compared to its own volatile history, the stock is near the top of its range on trailing earnings. The market is currently paying a premium for past performance but a deep discount for future promised profits, implying skepticism about the sustainability of the rebound.
GM is a high-risk, potentially high-reward stock that may be a good buy for specific investors. Its forward P/E of 5.63x offers deep value if the company delivers on its estimated $14.71 EPS. However, it is not a good buy for risk-averse investors due to extreme quarterly earnings volatility, as seen in the Q4 2025 net loss of -$2.70 billion. It could be a good buy for patient, value-oriented investors who believe in the earnings recovery narrative and can tolerate the stock's 1.3 beta and recent underperformance. A prudent approach would be to wait for confirmation of sustained profitability in upcoming quarters.
GM is more suitable for a medium- to long-term investment horizon, with a suggested minimum holding period of 12-18 months. This timeframe is necessary to see through the quarterly earnings volatility and allow the promised profit recovery narrative to play out. The stock's high beta of 1.3 and lack of a significant dividend (yield of 0.88%) make it a poor candidate for short-term trading or income-seeking investors. Long-term investors must be prepared for significant volatility but are betting on a cyclical recovery and multiple expansion from the current depressed forward valuation.